2530 Federal Register / Vol. 72, No. 12 / Friday, January 19, 2007 / Notices 

and 7,500 ineligible screened persons 

during a 3-year period. Data collection 

will rotate such that interviews will be 

conducted among one group per year: 

MSM in year 1, IDU in year 2, and HET 

in year 3. The type of data collected for 

each group will vary slightly due to 

different sampling methods and risk 

characteristics of the group. 

Participation of respondents is 

voluntary and there is no cost to the 

respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

MSM: 

Screener only ........................................................................................... 5,000 1 5/60 417 

Screener, survey, and testing .................................................................. 12,500 1 65/60 13,542 

IDU: 

Screener only ........................................................................................... 1,250 1 5/60 104 

Screener, survey, and testing .................................................................. 12,500 1 90/60 18,750 

HET: 

Screener only ........................................................................................... 1,250 1 5/60 104 

Screener, survey, and testing .................................................................. 12,500 1 75/60 15,625 

Total ................................................................................................... ........................ ........................ ........................ 48,542 

Dated: January 12, 2007. 

Deborah Holtzman, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E7–705 Filed 1–18–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Breast and Cervical Cancer Early 

Detection and Control Advisory 

Committee 

In accordance with section 10(a)(2)of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned 

committee meeting: 

Times and Dates: 8:30 a.m.–5 p.m., 

February 6, 2007; 8:30 a.m.–3 p.m., February 

7, 2007. 

Place: Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE., Tom 

Harkin Global Community Center, Building 

19, Atlanta, Georgia 30333, Telephone: 404–

639–1717. 

Status: Open to the public, limited only by 

the space available. 

Purpose: The committee is charged with 

advising the Secretary, Department of Health 

and Human Services, and the Director, CDC, 

regarding the early detection and control of 

breast and cervical cancer. The committee 

makes recommendations regarding national 

program goals and objectives; 

implementation strategies; and program 

priorities including surveillance, 

epidemiologic investigations, education and 

training, information dissemination, 

professional interactions and collaborations, 

and policy. 

Matters to be Discussed: The agenda will 

include a review and discussion of the 

National Breast and Cervical Cancer Early 

Detection Program components; and 

discussion and review of related policies and 

emerging issues. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Debra Younginer, Executive Secretary, 

BCCEDCAC, Division of Cancer Prevention 

and Control, National Center for Chronic 

Disease Prevention and Health Promotion, 

CDC, 4770 Buford Highway, Mailstop K–57, 

Chamblee, Georgia 30316, Telephone: 770–

488–1074. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and NCEH/ATSDR. 

Dated: January 12, 2007. 

Edward Schultz, 

Acting Director, Management Analysis and 

Services Office, Center for Disease Control 

and Prevention. 

[FR Doc. E7–721 Filed 1–18–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Clinical Laboratory Improvement 

Advisory Committee 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following committee 

meeting. 

Name: Clinical Laboratory Improvement 

Advisory Committee (CLIAC). Web site: 

http://www.phppo.cdc.gov/CLIAC/ 

default.aspx. 

Times and Dates: 8:30 a.m.–5 p.m., 

February 14, 2007; 8:30 a.m.–3 p.m., 

February 15, 2007. 

Place: Omni Hotel at CNN Center, 100 

CNN Center, Atlanta, Georgia 30303; Phone: 

(404) 659–0000, Fax: (404) 525–5050 (http:// 

www.omnihotels.com/FindAHotel/ 

AtlantaCNNCenter.aspx). 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 100 people. 

Purpose: This committee is charged with 

providing scientific and technical advice and 

guidance to the Secretary of Health and 

Human Services, the Assistant Secretary for 

Health, and the Director, CDC, regarding the 

need for, and the nature of, revisions to the 

standards under which clinical laboratories 

are regulated, the impact on medical and 

laboratory practice of proposed revisions to 

the standards, and the modification of the 

standards to accommodate technological 

advances. 

Matters to be Discussed: The agenda will 

include updates from the CDC, the Centers 

for Medicare & Medicaid Services, and the 

Food and Drug Administration; discussion of 

the status of the ‘‘Notice of Proposed 

Rulemaking’’ for genetic testing; 

presentations and discussion concerning the 

future of health laboratory practice 

specifically focusing on simple testing in 

diverse sites; reports and discussions 

addressing the impact of the Morbidity and 

Mortality Weekly Report (MMWR) 

Publication of ‘‘Good Laboratory Practices for 

Waived Testing Sites’’; a report from the 

CLIAC Workgroup on ‘‘The Impact of Rapid 

and Molecular Tests for Infectious Disease 

Agents on Public Health’’ and discussion of 

the workgroup’s proposals related to such; 

and presentations and discussion concerning 

rapid HIV testing. Agenda items are subject 

to change as priorities dictate. 

Providing Oral or Written Comments: It is 

the policy of CLIAC to accept written public 

comments and provide a brief period for oral 

public comments whenever possible. 


sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 72, No. 12 / Friday, January 19, 2007 / Notices 2531 

Oral Comments: In general, each 

individual or group requesting to make an 

oral presentation will be limited to a total 

time of five minutes (unless otherwise 

indicated). Speakers must also submit their 

comments in writing for inclusion in the 

meeting’s summary report. To assure 

adequate time is scheduled for public 

comments, individuals or groups planning to 

make an oral presentation should, when 

possible, notify the contact person below at 

least one week prior to the meeting date. 

Written Comments: For individuals or 

groups unable to attend the meeting, CLIAC 

accepts written comments until the date of 

the meeting (unless otherwise stated). 

However, the comments should be received 

at least one week prior to the meeting date 

so that the comments may be made available 

to the committee for their consideration and 

public distribution. Written comments, one 

hard copy with original signature, should be 

provided to the contact person below. 

Written comments will be included in the 

meeting’s summary report. 

Contact Person for Additional Information: 

Devery Howerton, Acting Chief, Laboratory 

Practice Standards Branch, Division Public 

Health Partnerships—Laboratory Systems, 

National Center for Health Marketing, 

Coordinating Center for Health Information 

and Service, CDC, 1600 Clifton Road, NE., 

Mailstop G–23, Atlanta, Georgia 30333; 

telephone (404) 718–1016; fax (404) 718–

1080; or via e-mail at DHowerton@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

CDC and the Agency for Toxic Substances 

and Disease Registry. 

Dated: January 12, 2007. 

Edward Schultz, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–720 Filed 1–18–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Environmental 

Health/Agency for Toxic Substances 

and Disease Registry; The Program 

Peer Review Subcommittee of the 

Board of Scientific Counselors (BSC), 

Centers for Disease Control and 

Prevention (CDC), National Center for 

Environmental Health/Agency for Toxic 

Substances and Disease Registry 

(NCEH/ATSDR): Teleconference 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), CDC, NCEH/ATSDR 

announces the aforementioned 

subcommittee meeting: 

Time and Date: 10 a.m.–12 p.m. Eastern 

Standard Time, February 6, 2007. 

Place: The teleconference will originate at 

NCEH/ATSDR in Atlanta, Georgia. To 

participate, dial 877/315–6535 and enter 

conference code 383520. 

Purpose: Under the charge of the BSC, 

NCEH/ATSDR, the PPRS will provide the 

BSC, NCEH/ATSDR with advice and 

recommendations on NCEH/ATSDR program 

peer review. They will serve the function of 

organizing, facilitating, and providing a longterm perspective to the conduct of NCEH/ 

ATSDR program peer review. 

Matters To Be Discussed: A discussion of 

Preparedness and Emergency Response Peer 

Review: (1) Breadth and approach of the 

review, (2) areas of expertise required for the 

review, and (3) nominations for a PPRS panel 

member, a chairperson, peer reviewers, 

partners and customers; a report on the Site 

Specific Activities Peer Review; and approval 

of the revised Peer Reviewer Conflict-ofInterest Form. 

Agenda items are subject to change as 

priorities dictate. 

Supplementary Information: This meeting 

is scheduled to begin at 10 a.m. Eastern 

Standard Time. To participate, please dial 

877/315–6535 and enter conference code 

383520. Public comment period is scheduled 

for 11 a.m.–11:10 a.m. 

For Further Information Contact: Sandra 

Malcom, Committee Management Specialist, 

Office of Science, NCEH/ATSDR, MS E–28, 

1600 Clifton Road, NE., Atlanta, Georgia 

30333, telephone 404/498–0622. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and NCEH/ATSDR. 

Dated: January 12, 2007. 

Edward Schultz, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–707 Filed 1–18–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–2786] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Fire Safety 

Survey Report Forms and Supporting 

Regulations in 42 CFR 416.44, 418.100, 

482.41, 483.70, and 483.470; Use: These 

forms are used by the State Agencies to 

record data collected to determine 

compliance with individual conditions 

during fire safety surveys and report it 

to the Federal Government. Form 

Number: CMS–2786 M, R, S, T, U, V, W, 

X, Y (OMB#: 0938–0242); Frequency: 

Reporting—Annually; Affected Public: 

State, Local or Tribal Government; 

Number of Respondents: 27,900; Total 

Annual Responses: 27,900; Total 

Annual Hours: 2,325. 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS Web site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or 

e-mail your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786–

1326. 

Written comments and 

recommendations for the proposed 

information collections must be mailed 

or faxed within 30 days of this notice 

directly to the OMB desk officer: OMB 

Human Resources and Housing Branch, 

Attention: Carolyn Lovett, New 

Executive Office Building, Room 10235, 

Washington, DC 20503, Fax Number: 

(202) 395–6974. 

Dated: January 10, 2007. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 07–154 Filed 1–18–07; 8:45 am] 

BILLING CODE 4120–01–P 


sroberts on PROD1PC70 with NOTICES